Table 8.
Parameter tissue | History (before challenge) | HP/LC history | LP/HC history | P value1 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
HP/LC | LP/HC | P value | CHO-M | CHO-H | CHO-M | CHO-H | History | Diet | Interactions | |
Liver glycolysis | ||||||||||
gck | 0⋅5 ± 0⋅2 | 1⋅5 ± 0⋅8 | 0⋅027 | 0⋅9 ± 0⋅6 | 0⋅8 ± 0⋅3 | 0⋅7 ± 0⋅4 | 0⋅6 ± 0⋅2 | 0⋅259 | 0⋅569 | 0⋅947 |
pfklr | 1⋅2 ± 0⋅6 | 1⋅2 ± 0⋅9 | 0⋅888 | 0⋅7 ± 0⋅2a | 0⋅4 ± 0⋅2b | 0⋅3 ± 0⋅1b | 0⋅3 ± 0⋅1b | 0⋅009 | 0⋅057 | 0⋅046 |
pklr | 1⋅0 ± 0⋅3 | 1⋅5 ± 0⋅7 | 0⋅088 | 1⋅0 ± 0⋅6 | 0⋅8 ± 0⋅5 | 1⋅0 ± 0⋅6 | 0⋅6 ± 0⋅2 | 0⋅418 | 0⋅122 | 0⋅503 |
Liver gluconeogenesis | ||||||||||
g6pca1 | 1⋅4 ± 0⋅7 | 0⋅9 ± 0⋅6 | 0⋅226 | 0⋅8 ± 0⋅5 | 0⋅6 ± 0⋅4 | 0⋅6 ± 0⋅4 | 0⋅4 ± 0⋅2 | 0⋅176 | 0⋅176 | 0⋅937 |
g6pca2 | 1⋅3 ± 1⋅0 | 0⋅6 ± 0⋅5 | 0⋅164 | 0⋅5 ± 0⋅3 | 0⋅4 ± 0⋅4 | 0⋅5 ± 0⋅3 | 0⋅2 ± 0⋅1 | 0⋅297 | 0⋅100 | 0⋅332 |
pck1 | 0⋅7 ± 0⋅4 | 0⋅6 ± 0⋅3 | 0⋅617 | 0⋅08 ± 0⋅07 | 0⋅78 ± 0⋅90 | 0⋅03 ± 0⋅06 | 0⋅07 ± 0⋅14 | 0⋅055 | 0⋅064 | 0⋅093 |
pck2 | 0⋅9 ± 0⋅5 | 0⋅4 ± 0⋅4 | 0⋅078 | 1⋅1 ± 0⋅7 | 0⋅5 ± 0⋅4 | 0⋅9 ± 0⋅6 | 0⋅6 ± 0⋅4 | 0⋅794 | 0⋅054 | 0⋅584 |
Liver lipogenesis | ||||||||||
fasn | 0⋅7 ± 0⋅4 | 1⋅2 ± 0⋅6 | 0⋅158 | 0⋅5 ± 0⋅3 | 0⋅9 ± 0⋅8 | 0⋅4 ± 0⋅2 | 0⋅9 ± 0⋅3 | 0⋅979 | 0⋅018 | 0⋅636 |
g6pd | 1⋅0 ± 0⋅3 | 1⋅6 ± 0⋅6 | 0⋅056 | 0⋅5 ± 0⋅3 | 0⋅8 ± 0⋅3 | 0⋅3 ± 0⋅2 | 1⋅0 ± 0⋅4 | 0⋅768 | 0⋅001 | 0⋅180 |
Liver amino acid catabolism | ||||||||||
asat | 1⋅3 ± 0⋅5 | 0⋅5 ± 0⋅3 | 0⋅049 | 0⋅6 ± 0⋅3 | 0⋅8 ± 0⋅4 | 0⋅5 ± 0⋅2 | 0⋅4 ± 0⋅3 | 0⋅046 | 0⋅727 | 0⋅311 |
alat | 1⋅3 ± 0⋅4 | 0⋅8 ± 0⋅4 | 0⋅048 | 1⋅4 ± 0⋅4 | 0⋅7 ± 0⋅4 | 0⋅7 ± 0⋅3 | 0⋅5 ± 0⋅3 | 0⋅005 | 0⋅007 | 0⋅137 |
gdh | 0⋅9 ± 0⋅3 | 1⋅4 ± 0⋅5 | 0⋅053 | 1⋅1 ± 0⋅3 | 0⋅8 ± 0⋅5 | 0⋅8 ± 0⋅3 | 0⋅6 ± 0⋅3 | 0⋅158 | 0⋅096 | 0⋅684 |
Glucose transport and Muscle metabolism | ||||||||||
glut4 | 0⋅7 ± 0⋅2 | 1⋅1 ± 0⋅5 | 0⋅152 | 0⋅8 ± 0⋅2ab | 0⋅6 ± 0⋅3b | 0⋅7 ± 0⋅4ab | 1⋅4 ± 0⋅8a | 0⋅060 | 0⋅157 | 0⋅030 |
hk1 | 0⋅9 ± 0⋅2 | 1⋅5 ± 0⋅4 | 0⋅009 | 0⋅9 ± 0⋅3 | 1⋅0 ± 0⋅5 | 0⋅8 ± 0⋅3 | 1⋅4 ± 0⋅7 | 0⋅605 | 0⋅092 | 0⋅207 |
hk2 | 1⋅0 ± 0⋅4 | 1⋅2 ± 0⋅2 | 0⋅250 | 1⋅2 ± 0⋅4 | 0⋅9 ± 0⋅2 | 0⋅6 ± 0⋅5 | 1⋅2 ± 0⋅6 | 0⋅411 | 0⋅388 | 0⋅040 |
pfkma | 0⋅7 ± 0⋅3 | 0⋅9 ± 0⋅4 | 0⋅369 | 1⋅0 ± 0⋅2 | 0⋅6 ± 0⋅2 | 0⋅6 ± 0⋅4 | 1⋅0 ± 0⋅5 | 0⋅865 | 0⋅873 | 0⋅019 |
pfkmb | 1⋅2 ± 0⋅4 | 0⋅8 ± 0⋅1 | 0⋅044 | 1⋅2 ± 0⋅4 | 1⋅2 ± 0⋅5 | 0⋅5 ± 0⋅1 | 0⋅5 ± 0⋅2 | <0⋅001 | 0⋅909 | 0⋅957 |
pkma | 0⋅5 ± 0⋅2 | 0⋅7 ± 0⋅2 | 0⋅030 | 1⋅2 ± 0⋅3 | 1⋅0 ± 0⋅5 | 0⋅7 ± 0⋅2 | 1⋅1 ± 0⋅3 | 0⋅179 | 0⋅357 | 0⋅035 |
Two-way ANOVA was used to analyse the effects of dietary stimulus (history), challenging diet (diet) and their interaction (history × diet). One-way ANOVA following Tukey's range test was used to rank the treatment combination groups when the interaction of the factors was statistically significant. Different letters indicate significant differences in the mean values for four combination groups (P < 0⋅05).